Skip to main navigation Skip to search Skip to main content

Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study

  • József Zsiros
  • , Laurence Brugieres
  • , Penelope Brock
  • , Derek Roebuck
  • , Rudolf Maibach
  • , Arthur Zimmermann
  • , Margaret Childs
  • , Daniele Pariente
  • , Veronique Laithier
  • , Jean-Bernard Otte
  • , Sophie Branchereau
  • , Daniel Aronson
  • , Arun Rangaswami
  • , Milind Ronghe
  • , Michela Casanova
  • , Michael Sullivan
  • , Bruce Morland
  • , Piotr Czauderna
  • , Giorgio Perilongo
  • , International Childhood Liver Tumours Strategy Group (SIOPEL)

Research output: Contribution to journalArticlepeer-review

136 Citations (Scopus)

Abstract

The objective of this study was to establish the efficacy and safety of a new treatment regimen consisting of dose-dense cisplatin-based chemotherapy and radical surgery in children with high-risk hepatoblastoma.
Original languageEnglish
Pages (from-to)834-842
JournalThe Lancet Oncology
Volume14
Issue number9
DOIs
Publication statusPublished - 3 Jul 2013

Bibliographical note

Copyright © 2013 Elsevier Ltd. All rights reserved.

Fingerprint

Dive into the research topics of 'Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study'. Together they form a unique fingerprint.

Cite this